CD8+ T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells
Menée à l'aide de modèles murins, cette étude met en évidence un mécanisme par lequel les lymphocytes T CD8+ exprimant CD40L induisent la mort des cellules cancéreuses
T cells and their effector functions, in particular the canonical cytotoxicity of CD8+ T cells involving perforin, granzymes, Fas ligand (FasL), and tumor necrosis factor related apoptosis inducing ligand (TRAIL), are crucial for tumor immunity. Here, we reveal a previously unidentified mechanism by which CD40L-expressing CD8+ T cells induce cytotoxicity in cancer cells. In murine models, up to 50% of tumor-specific CD8+ T cells expressed CD40L, and conditional CD40L ablation in CD8+ T cells alone led to tumor formation. Mechanistically, CD40L+CD8+ T cells can induce cell death in CD40-expressing cancer cells by triggering caspase-8 activation. We demonstrate that a gene signature for resistance to CD40 signaling–induced cell death strongly correlates with worse survival in different human cancer cohorts. Our results introduce CD40L as a rather counterintuitive, noncanonical cytotoxic factor that complements the capabilities of CD8+ T cells to combat cancers and has the potential to enhance the efficacy of immunotherapies. CD40L+CD8+ T cells reveal an unconventional way to kill cancer cells, offering the potential to boost immunotherapy effectiveness.
Science Advances , article en libre accès, 2025